NasdaqCM:PROK
NasdaqCM:PROKBiotechs

Promising Penny Stocks To Watch In December 2025

As the U.S. stock market experiences a slight uptick following a break in its recent winning streak, investors are closely monitoring the tech and crypto sectors for signs of rebound. Penny stocks, though often seen as remnants of past market eras, continue to capture attention due to their potential for growth at an affordable entry point. By focusing on companies with strong financials and clear growth trajectories, these smaller or newer entities can offer intriguing opportunities for...
NasdaqGS:XNET
NasdaqGS:XNETSoftware

Uncovering 3 US Hidden Gems with Strong Potential

As the U.S. stock market experiences a slight uptick following the end of a five-session winning streak, investors are closely watching tech and crypto-tied shares rebounding amidst fluctuating sentiment. In this dynamic environment, identifying stocks with solid fundamentals and growth potential can be crucial for navigating market volatility.
NYSE:CFR
NYSE:CFRBanks

Community Financial System And 2 Other Dividend Stocks To Enhance Your Portfolio

As the U.S. stock market experiences a slight uptick following a pause in its recent winning streak, investors are keenly observing how various sectors react to fluctuations in tech and crypto-tied shares. In this dynamic environment, dividend stocks like Community Financial System offer an appealing option for those looking to enhance their portfolios with steady income streams amidst market volatility.
NasdaqGS:ZVRA
NasdaqGS:ZVRAPharmaceuticals

Zevra Therapeutics (ZVRA): Evaluating Valuation Following High-Profile Board Appointment and CFO Transition

Zevra Therapeutics (ZVRA) is drawing attention this week as it welcomes Alicia Secor to its Board of Directors and prepares for the departure of CFO and Treasurer R. LaDuane Clifton at the end of the year. See our latest analysis for Zevra Therapeutics. The spotlight on Zevra Therapeutics follows a period of executive change amid a dip in momentum, with the shares sliding 18% over the past month and posting a 1-year total shareholder return of -11%. Still, the three-year total return stands...
NYSE:ARLO
NYSE:ARLOElectronic

Does Ongoing CEO Insider Selling at Arlo Technologies (ARLO) Reveal Shifting Management Sentiment?

On December 1, 2025, Arlo Technologies CEO Matthew Mcrae sold 257,242 shares, continuing a year-long trend of insider sales and no insider purchases at the company. This pattern of persistent insider selling, particularly from the CEO, is uncommon and can be an important signal for investors monitoring executive sentiment. To better understand the implications of such substantial insider sales, we'll review how this development may influence Arlo Technologies' investment narrative. Find...
NasdaqGS:WB
NasdaqGS:WBInteractive Media and Services

Weibo (NasdaqGS:WB): Assessing Valuation After Profitability Surges on Latest Earnings Results

Weibo (NasdaqGS:WB) just posted its third quarter earnings, drawing attention as net income and earnings per share jumped sharply compared to last year, even though the company saw slightly lower revenue. See our latest analysis for Weibo. Since the start of the year, Weibo’s share price has gained 10.78%, and its 12-month total shareholder return sits at 15.62%. This suggests recent momentum has started to build, even as long-term returns remain challenged. This performance follows sharply...
NYSE:HUN
NYSE:HUNChemicals

Can a Temporary Shutdown at Huntsman (HUN) Reveal Deeper Resilience in Its Recovery Story?

Huntsman Corporation recently announced that an unplanned disruption at its Rotterdam polyurethanes facility led to a downward revision of its fourth-quarter 2025 adjusted EBITDA forecast, following a shutdown of the larger MDI production line. This incident is expected to reduce quarterly EBITDA by approximately US$10 million, with production at the affected line projected to resume by mid-December 2025. We’ll explore how the unexpected plant shutdown and lowered earnings forecast could...
NYSE:ZBH
NYSE:ZBHMedical Equipment

Should Investors Rethink Zimmer Biomet After a 9.3% Drop in 2025?

Curious if Zimmer Biomet Holdings is a hidden bargain or just fairly priced? Let’s dig into what’s really driving the value behind the ticker. The company’s stock has slipped recently, down 2.4% in the past week and 9.3% year-to-date, which might have shifted how investors are thinking about its future growth or risk. Some of these price changes come off broader market talk around the healthcare sector’s evolving landscape, including regulatory headlines and ongoing product innovation. These...
NYSE:GATX
NYSE:GATXTrade Distributors

How Stalled Railcar Growth and Balance Sheet Strain at GATX (GATX) Has Changed Its Investment Story

In recent months, GATX has faced challenges with stagnant active railcar growth and heightened financial pressures, including ongoing cash burn and a significant debt burden. This combination has raised industry concerns about the company's ability to expand its fleet and manage capital requirements without resorting to potential shareholder dilution. We'll examine what GATX's stalled railcar growth and balance sheet stress could mean for its future business outlook and investment...
NYSE:WTM
NYSE:WTMInsurance

How White Mountains Insurance Group’s US$300 Million Share Buyback (WTM) Has Changed Its Investment Story

White Mountains Insurance Group, Ltd. recently announced a share repurchase program to buy back up to US$300 million of its shares at prices between US$1,850 and US$2,050 per share, with the offer set to expire on December 19, 2025. This initiative will be funded from available cash resources, including proceeds from asset sales, and is aimed at deploying unallocated capital while offering shareholders increased liquidity. We'll explore how the allocation of un-deployed capital toward this...
NYSE:PRM
NYSE:PRMChemicals

What Perimeter Solutions (PRM)'s Analyst Upgrades and Earnings Forecast Revisions Mean For Shareholders

Earlier this year, Perimeter Solutions, SA received a Zacks Rank #1 (Strong Buy) after analyst sentiment improved and full-year earnings estimates were raised by 23.6%. This significant upgrade was accompanied by a surge in analyst expectations, positioning Perimeter Solutions as a standout within the Basic Materials sector so far in 2025. We'll explore how the recent analyst upgrades and rising earnings forecasts influence the company's overall investment narrative. AI is about to change...
NasdaqGS:BSY
NasdaqGS:BSYSoftware

Bentley Systems (BSY): Valuation Insights Following Dividend, Buyback Expansion, and Infrastructure AI Developments

Bentley Systems (BSY) made headlines after announcing a $0.07 dividend for the fourth quarter, expanding its share repurchase plan, and reporting healthy double-digit revenue growth. Management also highlighted new AI-powered infrastructure solutions, which are fueling optimism about future performance. See our latest analysis for Bentley Systems. Bentley Systems has seen its share price retreat about 18% over the past month and slide more than 21% over the last quarter, reflecting a shift in...
NYSE:WHD
NYSE:WHDEnergy Services

Is Strong International Growth Offsetting Core Headwinds for Cactus (WHD)?

In the past week, Cactus, Inc. reported third-quarter 2025 adjusted earnings of 67 cents per share, surpassing analyst estimates despite a year-over-year decrease, supported by reduced legal expenses and rising international sales in the Spoolable Technologies segment. An important insight from this announcement is that Cactus managed to outperform expectations even while experiencing offsetting lower activity levels in its core business. We'll now explore how the strong performance in...
NasdaqGS:COLB
NasdaqGS:COLBBanks

Dividend Hike and Leadership Change Could Be a Game Changer for Columbia Banking System (COLB)

Columbia Banking System recently increased its dividend and announced key executive leadership changes, appointing Brock Lakely as Executive Vice President, Chief Accounting Officer, and Corporate Controller following the departure of Lisa M. White in November 2025. This development highlights the company's ongoing focus on earnings stability, operational leadership, and commitment to consistent capital returns for shareholders. We'll explore how the company's dividend increase signals...
NasdaqCM:ASPI
NasdaqCM:ASPIChemicals

ASP Isotopes (ASPI) Is Down 6.8% After Deeper Losses Despite Revenue Growth in Q3 Results - Has The Bull Case Changed?

ASP Isotopes Inc. recently reported earnings for the third quarter and nine months ended September 30, 2025, showing revenue growth to US$4.89 million in the quarter but a net loss of US$12.87 million. Despite higher revenue year-over-year, the increase in net loss and basic loss per share highlights ongoing financial pressures facing the company. We'll examine how the considerable increase in net losses informs ASP Isotopes' current investment narrative and key investor concerns. The end of...
NasdaqCM:CMPX
NasdaqCM:CMPXBiotechs

Compass Therapeutics (CMPX) Up 9.0% After Advancing Oncology Pipeline Updates at Key Healthcare Conference

At the Piper Sandler 37th Annual Healthcare Conference in New York, Compass Therapeutics provided updates on its oncology pipeline, including progress for investigational candidates CTX-10726 and tovecimig. Analyst commentary highlighted the company's strong preclinical and early clinical results, with management reiterating timelines for key data releases and a possible first regulatory filing in 2026. We'll explore how investor enthusiasm for Compass Therapeutics' advancing pipeline,...
NYSE:AMRC
NYSE:AMRCConstruction

Ameresco (AMRC): Exploring the Current Valuation After a Week of Renewed Share Price Momentum

Ameresco (AMRC) shares have gained 1% over the past day and are up nearly 7% for the week. Investors may be watching the stock after its recent month of volatility, looking for cues about its direction ahead. See our latest analysis for Ameresco. Ameresco’s 90-day share price return of 37.3% shows how quickly momentum can build following recent volatility. Its 1-year total shareholder return stands at 21.7%. Short-term swings hint at renewed optimism, but the longer view reminds us just how...